Published March 2012
| Version v1
Journal article
Progress on p73 variant and its possible application in tumor radiotherapy
- 1. Key Laboratory of Heavy Ion Radiation Medicine of Gansu Prevince, Lanzhou (China)
- 2. Key Laboratory of Heavy Ion Radiation Biology and Medicine of Chinese Academy of Sciences, Lanzhou (China)
- 3. Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou (China)
Description
p73 was the first identified homologue of the tumor suppressor gene, p53. p73 has two groups of protein isoforms: TAp73 and DNp73. TAp73 can induce cell cycle arrest, resulting in the ability of apoptosis, however DNp73 has antagonistic property of a tumor promoting effect. In this paper, the dual roles of p73 gene and its research progress was reviewed. Finally, combined with heavy ion treatment of tumor, we explored some new ideas of p73-heavy ion joint therapy. (authors)
Additional details
Publishing Information
- Journal Title
- Nuclear Physics Review
- Journal Volume
- 29
- Journal Issue
- 1
- Journal Page Range
- p. 103-108
- ISSN
- 1007-4627
INIS
- Country of Publication
- China
- Country of Input or Organization
- China
- INIS RN
- 45059216
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- APOPTOSIS; CELL CYCLE; GENES; HEAVY IONS; NEOPLASMS; PROTEINS; RADIOTHERAPY
- Descriptors DEC
- CHARGED PARTICLES; DISEASES; IONS; MEDICINE; NUCLEAR MEDICINE; ORGANIC COMPOUNDS; RADIOLOGY; THERAPY
Optional Information
- Notes
- 3 figs., 1 tabs., 39 refs.